Irofulven induces replication-dependent CHK2 activation related to p53 status
- 15 February 2007
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 73 (4), 469-480
- https://doi.org/10.1016/j.bcp.2006.10.023
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Checkpoint Kinase 2–Mediated Phosphorylation of BRCA1 Regulates the Fidelity of Nonhomologous End-JoiningCancer Research, 2006
- Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaksOncogene, 2004
- The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastropheOncogene, 2004
- Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidyOncogene, 2004
- Replication Checkpoint Kinase Cds1 Regulates Recombinational Repair Protein Rad60Molecular and Cellular Biology, 2003
- The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer CellsOnline Journal of Public Health Informatics, 2003
- PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2Nature, 2002
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Increased expression of CHK2 in human gastric carcinomas harboringp53 mutationsInternational Journal of Cancer, 2002
- The hCds1 (Chk2)-FHA Domain Is Essential for a Chain of Phosphorylation Events on hCds1 That Is Induced by Ionizing RadiationOnline Journal of Public Health Informatics, 2001